About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

SEC Names Kathleen Weiss Hanley as Deputy Chief Economist and Deputy Director of Riskfin

Subscribe to our newsletter

The Securities and Exchange Commission today announced that Kathleen Weiss Hanley has been named Deputy Director and Deputy Chief Economist for the SEC’s Division of Risk, Strategy, and Financial Innovation (RiskFin).

RiskFin was created in September 2009 to provide interdisciplinary analysis to help inform the Commission’s policymaking, rulemaking, enforcement, and examinations. The division encompasses the former Office of Economic Analysis, Office of Risk Assessment, and Office of Interactive Disclosure. Its staff has expertise in disciplines including economics, risk analysis, finance, law, mathematics and statistics.

As Deputy Director and Deputy Chief Economist, Dr. Hanley will play an integral role in the division’s economic analysis of policymaking, particularly cost-benefit analysis. She also will be responsible for directing and coordinating the division’s research activities.

“Dr. Hanley is a distinguished financial economist with significant experience in variety of regulatory settings, having recently joined us from the Federal Reserve Board, and has an unparalleled reputation for conducting high-quality financial research,’ said RiskFin Director and SEC Chief Economist Craig Lewis. “She will be instrumental in our ongoing efforts to improve the economic analysis in our rulemakings.”

Dr. Hanley began her new role on August 22. She previously served as a Senior Economist at the Board of Governors of the Federal Reserve System. From 2005 to 2010, she was a Senior Financial Economist in the SEC’s Office of Economic Analysis and later in RiskFin. Before that, she was on the faculty at the University of Michigan and the University of Maryland. She holds an undergraduate degree from Indiana University and received her Ph.D. from the University of Florida while visiting the SEC as a graduate student.

Dr. Hanley’s academic work focuses on securities issuance, market microstructure, and structured finance. She has published widely on litigation risk in offerings, information content of prospectuses, short selling in IPOs, closed-end fund discounts, price stabilization, and venture capital. In addition to her academic background, “her familiarity with the SEC allows her to hit the ground running,” said Lewis.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: How to leverage data lineage for actionable business insights

Data lineage is a must-have for financial institutions, but is it being used to its greatest extent, and is it delivering actionable business insights that inform product development and support competitive advantage? This webinar will address these questions, looking first at the status quo of data lineage across capital markets, and moving on to discuss...

BLOG

US ESG Pullback Opens a New Competitive Question

US resistance to sustainability disclosure at state and federal level is widening the regulatory gap for US-domiciled firms operating internationally. In March 2025, the Securities and Exchange Commission (SEC) voted to end its defence of federal climate-disclosure rules. In December 2025, the White House issued an executive order targeting proxy advisers accused of promoting ESG...

EVENT

Buy AND Build: The Future of Capital Markets Technology

Buy AND Build: The Future of Capital Markets Technology London examines the latest changes and innovations in trading technology and explores how technology is being deployed to create an edge in sell side and buy side capital markets financial institutions.

GUIDE

What the Global Legal Entity Identifier (LEI) Will Mean for Your Firm

It’s hard to believe that as early as the 2009 Group of 20 summit in Pittsburgh the industry had recognised the need for greater transparency as part of a wider package of reforms aimed at mitigating the systemic risk posed by the OTC derivatives market. That realisation ultimately led to the Dodd Frank Act, and...